Natco Pharma Limited has informed the Exchange about Copy of Newspaper Publication
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natco Pharma has submitted copies of newspaper advertisements published on February 13, 2026 in Business Line, Financial Express, and Nava Telangana, as required under SEBI's Listing Regulations. The publications cover two items: (1) the company's unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, which were approved by the Board on February 12, 2026; and (2) a notice of the record date for the 3rd Interim Dividend declared for FY 2025-26. The full results and a press release are available on the company's website and on the NSE/BSE portals. The record date appears to be February 18, 2026, with dividend payment around February 26, 2026.
This is a routine compliance filing confirming that the Q3 results and dividend record date have been published in newspapers as required — no new financial details beyond what was already disclosed. Shareholders should focus on the underlying Q3 results announcement and the interim dividend declaration for the real market impact.